Clinical Trials Logo

Filter by:
NCT ID: NCT02061670 Completed - Asthma Clinical Trials

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Start date: January 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether it is safe to administer Ragweed-SPIRE to subjects suffering from both ragweed allergy and asthma.

NCT ID: NCT02061540 Completed - Clinical trials for Primary Sclerosing Cholangitis (PSC)

Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis

CAMEO
Start date: March 2014
Phase: Phase 2
Study type: Interventional

The study is an open-label study in adults with primary sclerosing cholangitis to evaluate the safety, tolerability, and effect of 14-weeks of daily dosing of LUM001.

NCT ID: NCT02061319 Completed - Heart Failure Clinical Trials

Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure

Start date: March 2014
Phase: N/A
Study type: Interventional

The main purpose of our project is to see if a 12-week program of Nordic walking is better than standard exercise therapy for increasing exercise capacity (measured by how far people can walk in 6 minutes) and increasing quality of life (measured by having people fill out two questionnaires). We will also see if Nordic walking: improves heart performance (measured by heart ultrasound); improves how active people are (measured by an activity monitor); increases aerobic fitness (measured by a treadmill test); improves body composition (measured by waist size); and reduces hormone levels in the blood.

NCT ID: NCT02061072 Completed - Hemophilia A Clinical Trials

Web-based Application for the Population Pharmacokinetic Service - Phase 1

WAPPS
Start date: January 2015
Phase:
Study type: Observational [Patient Registry]

The aims of this trials are: 1. to collect published and unpublished individual classic pharmacokinetic data (individual patient data from independent investigators and pharmaceutical companies) 2. to make available population pharmacokinetic models for the concentrates derived from the data collected 3. to develop a web based application intended to use the above models to calculate pharmacokinetic parameters for individual patients, and 4. to test the system functionality via simulation of the use of the prototype by use of faked test data.

NCT ID: NCT02060708 Completed - Motor Task Clinical Trials

Determining the Specificity of High Definition Electrical Brain Stimulation Using Simultaneous Magnetoencephalography

Start date: January 2015
Phase: N/A
Study type: Interventional

Non-invasive human brain stimulation using weak transcranial direct‐current stimulation (tDCS) has been thousands of times in research studies over the past fifteen years as a therapy to help improve the effectiveness of repeated training sessions (e.g., hand exercises in the context of daily physiotherapy), due to its safety, tolerability, convenience and cost‐effectiveness. tDCS works by temporarily enhancing brain activity during performance of a specific task, helping with learning and training. The investigators will use magnetoencephalography (MEG) brain imaging to view the real‐time effects of high definition (HD) tDCS on several brain areas involved in vision, hearing, movement, and memory. The investigators hypothesize that changing the task (auditory, visual or memory task) but keeping the position of the electrodes over the motor cortex will result in modulation of brain activity in only the central target motor area, and not on non-target temporal, occipital or pre-frontal areas.

NCT ID: NCT02060630 Completed - Clinical trials for Critical Limb Ischemia

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia

BEST-CLI
Start date: August 2014
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.

NCT ID: NCT02060539 Completed - Myopia Clinical Trials

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

Start date: October 2013
Phase: N/A
Study type: Interventional

To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.

NCT ID: NCT02060227 Completed - Clinical trials for Anterior Shoulder Instability

Approach to Shoulder Instability

Start date: March 5, 2014
Phase: N/A
Study type: Interventional

The primary research question is to determine whether patients who undergo a stabilization of the shoulder using a novel decision-making algorithm (ISIS Score) have improved disease-specific quality of life at 1 year post-operatively, as measured by the Western Ontario Instability Index (WOSI) compared with patients who undergo stabilization using a conventional decision-making algorithm. Secondary outcomes include the American Shoulder and Elbow Surgeon's (ASES) score, and difference in recurrence rates of dislocation between the two decision-making algorithms.

NCT ID: NCT02059395 Completed - Cardiac Arrest Clinical Trials

Mastery Learning Versus Time-based Education: Skill Acquisition and Retention of Basic Life Support in Laypeople

Start date: November 2013
Phase: N/A
Study type: Interventional

Background: In cardiac arrest survival rates dramatically increase when bystanders are present and initiate Basic Life Support (BLS). However, even though serious efforts have been made, skill retention after a traditional time-based BLS course for laypeople remains suboptimal. In contrast, a mastery learning-based educational approach was shown to be efficacious and might be promising even for laypersons. Therefore the investigators aim to evaluate the impact of a mastery learning-based BLS course on skills retention of BLS in laypeople. Methods: Forty laypeople without previous BLS experiences will be randomized into the traditional time-based BLS course group (Control - TB group) or mastery learning-based group (Intervention - ML group). Both groups will receive BLS training consisting of 6 successive stations including diagnosis of cardiac arrest, chest compression, ventilation, one-rescuer BLS, two-rescuer BLS and AED use. In the ML group, subjects will deliberately practice and receive feedback at each station until a pre-set target level is reached. Subjects will be allowed to proceed to the next station only when they achieve the required target level of performance. In contrast, participants of the TB group will be taught the same 6 stations in two hours, according to standard American Heart Association BLS criteria. All subjects will have an assessment of knowledge and skills immediately after teaching (immediate post-test) and at four months (retention post-test). Implications: Previous research has shown that mastery learning-based education improves learners' procedural skill performance. The investigators study will determine the impact of a mastery learning-based BLS course on skill retention in laypeople.

NCT ID: NCT02059291 Completed - Clinical trials for Hereditary Periodic Fevers

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Start date: June 27, 2014
Phase: Phase 3
Study type: Interventional

This study is to determine whether canakinumab is able to induce and maintain a clinically meaningful reduction of disease activity in participants with Hereditary Periodic Fevers (HPF) compared to placebo.